Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,461 to 1,480 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNAs overexpressed in Crohn's disease and their interactions with mechanisms of epigenetic regulation explain novel aspects of Crohn's disease pathogenesis. | Clin Epigenetics | 2021 | 33602320 | PubTator, text mining | PubMed |
| Coming together at the hinges: Therapeutic prospects of IgG3. | MAbs | 2021 | 33602056 | PubTator, text mining | PubMed |
| Four keys to unlock IgG. | J Exp Med | 2021 | 33600555 | PubTator, text mining | PubMed |
| Virus infection of the CNS disrupts the immune-neural-synaptic axis via induction of pleiotropic gene regulation of host responses. | Elife | 2021 | 33599611 | PubTator, text mining | PubMed |
| Nanobody Nb6 fused with porcine IgG Fc as the delivering tag to inhibit porcine reproductive and respiratory syndrome virus replication in porcine alveolar macrophages. | Vet Res | 2021 | 33596995 | PubTator, text mining | PubMed |
| Tissues: the unexplored frontier of antibody mediated immunity. | Curr Opin Virol | 2021 | 33581646 | PubTator, text mining | PubMed |
| Accelerated Clearance and Degradation of Cell-Free HIV by Neutralizing Antibodies Occurs via FcγRIIb on Liver Sinusoidal Endothelial Cells by Endocytosis. | J Immunol | 2021 | 33568400 | PubTator, text mining | PubMed |
| Human antiviral B cell responses: Emerging lessons from hepatitis B and COVID-19. | Immunol Rev | 2021 | 33559128 | PubTator, text mining | PubMed |
| Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular phagocytosis. | Oncoimmunology | 2021 | 33552684 | PubTator, text mining | PubMed |
| VNTR2/VNTR3 genotype in the FCGRT gene is associated with reduced effectiveness of intravenous immunoglobulin in patients with myasthenia gravis. | Ther Adv Neurol Disord | 2021 | 33552238 | PubTator, text mining | PubMed |
| The Influence of Immune Immaturity on Outcome After Virus Infections. | J Allergy Clin Immunol Pract | 2021 | 33551039 | PubTator, text mining | PubMed |
| Do rogue antibodies make the difference between mild versus severe COVID-19? | Nat Rev Immunol | 2021 | 33542500 | PubTator, text mining | PubMed |
| In-silico network-based analysis of drugs used against COVID-19: Human well-being study. | Saudi J Biol Sci | 2021 | 33519272 | PubTator, text mining | PubMed |
| Allergen skin test reactivity and asthma are inversely associated with ratios of IgG4/IgE and total IgE/allergen-specific IgE in Ugandan communities. | Clin Exp Allergy | 2021 | 33512036 | PubTator, text mining | PubMed |
| Refreshing the biologic pipeline 2020. | Nat Biotechnol | 2021 | 33510484 | PubTator, text mining | PubMed |
| Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis. | Nat Commun | 2021 | 33504803 | PubTator, text mining | PubMed |
| Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032. | Clin Cancer Res | 2021 | 33504555 | PubTator, text mining | PubMed |
| Use of 5-Thio-L-Fucose to modulate binding affinity of therapeutic proteins. | Biotechnol Bioeng | 2021 | 33501689 | PubTator, text mining | PubMed |
| Novel myostatin-specific antibody enhances muscle strength in muscle disease models. | Sci Rep | 2021 | 33495503 | PubTator, text mining | PubMed |
| Using iPSC Models to Understand the Role of Estrogen in Neuron-Glia Interactions in Schizophrenia and Bipolar Disorder. | Cells | 2021 | 33494281 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=74